OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Japan Approves Bayer’s Sevabertinib for HER2-Mutant NSCLC Across All Lines of Therapy

10 Must-Read Posts In GI Oncology This Week

Do Energy Drinks Cause Cancer? Myths, Facts, and What Science Really Shows

Dato-DXd in Lung Cancer: International Experts Define New Strategies to Manage ADC Toxicities

Fabio Moraes: Can We Trust AI in Radiation Oncology? A Practical Perspective

Oncology News, Insights, Stories by OncoDaily

Jarbas Barbosa
OncoDaily Magazine

Jarbas Barbosa: The Future of Global Health Starts in Countries

FDA
Societies

FDA Published 55 Product-Specific Guidances to Accelerate Generic Drug Development

Erasca
Public Health

Erasca Receives FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Metastatic Pancreatic Cancer

Multiple Myeloma in 2026: Comprehensive Clinical Update

Douglas Flora: Making Mental Health Part of Cancer Care

Pavlos Msaouel: New Therapeutic Insights in Renal Medullary Carcinoma

Lacy Hubbard: 5 African Nations Unite With the Elekta Foundation to Eliminate Cervical Cancer

Karen Knudsen’s Exclusive Commentary on the New Moderna Cancer Vaccine

Hesham ElGhazaly: Building Egypt’s Next Generation of Liver Cancer Research

Lung Cancer Immunotherapy: Real-World Survival and Costs in France

Voices
Sandra Demaria

Sandra Demaria։ Tumour-infiltrating Lymphocytes and Breast Radiotherapy

September is Childhood Cancer Awareness Month - The Dorcas Cancer Foundation

Mitchell Elliott։ Unified Network for Integrated Fluid Collection at Yale is Օfficially Օpen

Judit Merino Moreno։ Equipping T Cells to Function Within the Tumour Microenvironment

Stephen Liu: Proud to Have Co-edited the 3rd Edition of the ESMO 'Thoracic Tumours: Essentials for Clinicians'

Luis Álvarez-Vallina։ Pharmacological Control Advances STAb-T Cancer Immunotherapy

John Hennessy։ Incentive Bonuses for Nurse Practitioner Mentoring

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

The Milken Institute Future of Health Summit 2026

Milken Institute

11 Nov
Future of Health Summit

The European Lung Cancer Congress 2027

European Society For Medical Oncology (ESMO)

17 Mar
European Lung Cancer Congress

The 2027 Pan-Africa Conference on Lung Cancer

International Association for the Study of Lung Cancer (IASCL)

22 Jan
Pan-Africa Conference on Lung Cancer

The ITMIG and LALCA26 Joint Conference

IASLC Latin America Conference on Lung Cancer (LALCA)

12 Nov
LALCA26

ESSO Webinar: Advances in Breast Cancer Surgery - ICG Fluorescence Imaging

European Society of Surgical Oncology

10 Sep
Advances in Breast Cancer Surgery

Immune-oncology
CD20 × CD3 Bispecific Antibodies LBCL

CD20 × CD3 Bispecific Antibodies in B-Cell Lymphoma: Real-World Safety, Efficacy, and Healthcare Use in Spain

5 Must-Read Posts About CAR-T This Week

Lung Cancer Immunotherapy: Real-World Survival and Costs in France

INTerpath-001 Trial: Personalized mRNA Cancer Vaccine for Melanoma

Tumor Mutational Burden in Immunotherapy: Why TMB Is More Than a Number

CheckMate 77T study: Can ctDNA Predict Response to Perioperative Immunotherapy in NSCLC?

PIVOTAL Trial: Neoadjuvant Intralesional Immunotherapy in Melanoma

Gastrointestinal-Oncology
TALENTOP

TALENTOP: Liver Resection After Atezolizumab and Bevacizumab in Locally Advanced HCC

10 Must-Read Posts In GI Oncology This Week

ctDNA Identifies High Recurrence Risk After Resection of Stage I–III Biliary Tract Cancer

Comprehensive Genomic Profiling in GI Oncology: Real-World Impact and Challenges

ESMO Clinical Practice Guideline Express Update: Daraxonrasib for Metastatic Pancreatic Cancer

GI Cancers Alliance: Could Cancer Vaccines Change the Future of Lynch Syndrome and GI Cancers?

FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma

Breast-Oncology
Oncotype DX

Oncotype DX-Guided Chemotherapy Associated With Improved Survival in HR+/HER2− Breast Cancer

Insights From I-SPY2 Trial: Dual Immune Checkpoint Blockade Shows Promise in High-Risk ERBB2-Negative Early Breast Cancer

TQB2102 and the Evolution of HER2 Antibody-Drug Conjugates: Exploring the Role of Payload Optimisation in Breast Cancer

HER2DX Predicts Pathologic Complete Response in HER2-Positive Breast Cancer After Neoadjuvant THP

Neo-CheckRay: iSBRT and Durvalumab in High-Risk ER+/HER2− Breast Cancer

HER2DX in Early HER2-Positive Breast Cancer: Toward Biology-Guided Treatment Intensity

Breast Cancer in 2026: Molecular Interception, MRD, ADC Sequencing and De-Escalation

Lung-Oncology
Dato-DXd

Dato-DXd in Lung Cancer: International Experts Define New Strategies to Manage ADC Toxicities

Lung Cancer Screening in Women: 5 Breakthrough Insights Highlight New Risk Groups

MET Exon 14 Skipping NSCLC: DECIDE-MET Trial Addresses a Critical Question in First-Line Treatment Selection

KEYNOTE-671: Five-Year Data Confirm Durable Benefit of Perioperative Pembrolizumab in Early-Stage NSCLC

RAS-Mediated Resistance Emerges Across Oncogene-Driven NSCLC

CheckMate 77T: ctDNA Clearance and MRD Refine Risk After Perioperative Nivolumab

DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC

Genitourinary-Oncology
Prostate Cancer

Personalizing Treatment Intensity in Prostate Cancer: Less Is More… Until It Isn’t?

10 Must-Read Posts In GU Oncology This Week

Ahmed Mohsen Elalfy: Lessons From Practicing Oncology Across Egypt, Saudi Arabia, and Canada

Local Renal Cell Carcinoma Recurrence: Salvage Treatment Outcomes

AVENANCE: Real-World Avelumab Maintenance in Advanced Urothelial Carcinoma

ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC

TRUMPET Registry: mCRPC Treatment and Outcomes by Race, Initial Diagnosis, and Family History

OncoDaily-AI
Maria García Requesens

Maria García Requesens: The Growing Role of AI in Oncology Drug Development

Jorge Reis-Filho: AI’s Next Breakthrough Could Be Biomedical Discovery

Anthropic's AI Protein Design Run: 354 Binders, 15 Targets

Anirudh Joshi: A New AI Biomarker to Predict Aggressiveness of MIBC

Oncology Tech
Moderna

Moderna Stock Surge Explained: How INTerpath-001 Added $45 Billion in a Day and What Oncologists Should Actually Watch

Anthropic's AI Protein Design Run: 354 Binders, 15 Targets

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

Hematology
Inflammation and JAK2 Burden in Polycythemia Vera

Inflammation and JAK2 Burden in Polycythemia Vera: Interferon, Ruxolitinib, and Clonal Control 

Multiple Myeloma in 2026: Comprehensive Clinical Update

Central Nervous System (CNS) Lymphoma: Reaching the Tumor Across CNS Barriers

VEXAS Syndrome: Is It More a Matter of Inflammation or Hematopoietic Clonality?

Venetoclax + HMA in Newly Diagnosed AML: What Do Real-World Data Show?

BeOne, BeOne Care Foundation and The Max Foundation Renew BRUKINSA Access Partnership for CLL in LMICs

TP53-Mutated MDS: Can New Therapies Change the Prognosis?

Radiotherapy
radiotherapy

10 Must-Read Posts In Radiotherapy This Week: August 17 -23

EANO Consensus Statement Guides Diagnosis and Management of Radiation Necrosis

Neoadjuvant SBRT and Immunotherapy Show Potential in High-Risk ER+/HER2− Breast Cancer

Call for Papers: “Radiation Oncology in 2026” Special Series

10 Must-Read Posts In Radiotherapy This Week: August 10-16

Mayo Clinic Reports First Clinical Series of Minibeam Radiation Therapy for Superficial Malignancies

TREASURE Trial Raises Safety Concerns Over Thoracic Radiotherapy in ES-SCLC

OncoDaily TV
Dr. Beatrice Addai Wiafe

Fighting Cancer With Peace And Love: Dr. Beatrice Addai Wiafe

Maggie Smith breast cancer

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Empowering Oncologist

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessable for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

Not To Miss
10 Cancer Research Grants

Top 10 Cancer Research Grants Open to Researchers Worldwide

Astellas Doses First Patient in Phase 3 ASP2138 Trial for CLDN18.2-Positive Gastric and GEJ Cancer

AAADV Leaders on the Shifting Landscape of Global Cancer Drug Development

FDA Grants Priority Review to GSK’s Jemperli for dMMR/MSI-H Locally Advanced Rectal Cancer

European Commission has Granted Marketing Authorization for Gilead Sciences’ Trodelvy Plus Keytruda for First-Line PD-L1-Positive Metastatic TNBC

Japan Approves Bayer’s Sevabertinib for HER2-Mutant NSCLC Across All Lines of Therapy

Jill Biden Shares Update on Joe Biden’s Latest Cancer Scans

OncoGrants
Cancer Research Alliance

Pershing Square Sohn Cancer Research Alliance Cancer Prize 2027

Prostate Cancer UK Internship Programme

Windsor Fellowship–Prostate Cancer UK Internship Programme 2026/27

Bio-Resource Coordinating Hub

CIHR Team Grant for National Cancer Data and Bio-Resource Coordinating Hub 2026–2027

Brain Cancer Research Grant

MRFF Australian Brain Cancer Mission – 2026 Brain Cancer Research Grant

Oncology and Hematology Community Grants

Gilead/Kite Canada’s Oncology and Hematology Community Grants Program

Breath Research Award

Lung Cancer Canada Give a Breath Research Award 2026 for Advanced Lung Cancer

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Alessandro Russo

Alessandro Russo

Oncologists Location Milan, Italy
Jan Fagerberg

Jan Fagerberg

Oncologists Location Paris, France
Tetiana Shevchuk

Tetiana Shevchuk

Oncologists Location Kyiv, Ukraine
Roberto Carmagnani Pestana

Roberto Carmagnani Pestana

Oncologists Location São Paulo, Brazil
Leandro Jonata de Carvalho Oliveira

Leandro Jonata de Carvalho Oliveira

Oncologists Location São Paulo, Brazil
Antonio Lázaro Sánchez

Antonio Lázaro Sánchez

Oncologists Location El Palmar, Spain
Matheus de Oliveira Andrade

Matheus de Oliveira Andrade

Oncologists Location Brasília, Brazil
Rob Pieters

Rob Pieters

Oncologists Location Utrecht, Netherlands

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Felipe Couñago

Felipe Couñago: Whole-Pelvis Radiotherapy Shows No Overall Survival Benefit

Al-Ola Abdallah

Al-Ola A Abdallah: What Did We Learn From the CANOVA Phase III Trial?

Miguel Bronchud

Miguel Bronchud: Does More Drugs Mean Better Outcomes in dMMR Colorectal Cancer?

Felipe Couñago

Felipe Couñago: Rethinking Pelvic Irradiation in High-Risk Prostate Cancer

Pavlos Msaouel

Pavlos Msaouel: New Therapeutic Insights in Renal Medullary Carcinoma

Carmen Saiz Guisasola

Carmen Saiz Guisasola: Dose-Escalated TNT Shows Promise in Rectal Cancer

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries